Norden Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Norden Group's BMY Position: Q3 2026 in Review
Norden Group reduced its Bristol-Myers Squibb (BMY) stake by 87% in Q3 2026, selling an estimated $12.4M and leaving 28,315 shares worth $1.77M. The position accounts for 0.13% of the portfolio, ranked #131.
Norden Group first reported a position in BMY in Q3 2023 and has held it in 13 quarters since. The position peaked at $12.9M in Q2 2026. 2,555 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Norden Group held 28,315 shares of Bristol-Myers Squibb worth $1.77M as of Q3 2026.
- Norden Group sold 195,574 Bristol-Myers Squibb shares in Q3 2026, an estimated $12.4M.
- Bristol-Myers Squibb made up 0.13% of Norden Group's portfolio in Q3 2026, its #131 holding.
- Norden Group first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 13 quarters since.
- Norden Group's Bristol-Myers Squibb position peaked at $12.9M in Q2 2026.
- 2,555 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Norden Group's 13F filing for Q3 2026, filed 20 Oct 2026.